Ovarian Cancer Awareness: A Declining Disease Rate, And Looking Ahead to New Drugs

September 9, 2014 12:35 AM

2 0

Ovarian Cancer Awareness: A Declining Disease Rate, And Looking Ahead to New Drugs

September is Ovarian Cancer Awareness Month. This insidious form of malignancy shares the official National Health Observances calendar educational slot with childhood cancers and prostate cancer, along with other medical conditions including sickle cell anemia. So I thought it worth noting what’s new about this insidious cancer.

Last week, researchers presented preliminary findings for an experimental drug, a PARP inhibitor called veliparib (AbbVie AbbVie, Inc.). The phase I trial included patients with ovarian cancer. Although it’s too early to draw conclusions about treatment or this drug’s effectiveness, the study caught...

Read more

To category page

Loading...